Publisher
Springer International Publishing
Reference47 articles.
1. Alkermes, Inc. (2010). Vivitrol (naltrexone for extended-release injectable suspension) package insert. Retrieved December 1, 2017, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021897s015lbl.pdf
2. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.
3. Berde, C. B., Beyer, J. E., Bournaki, M. C., Levin, C. R., & Sethna, N. F. (1991). Comparison of morphine and methadone for prevention of postoperative pain in 3- to 7-year-old children. The Journal of Pediatrics, 119(1 Pt 1),136–41.
4. Blazes, C. K., & Morrow, J. D. (2020). Reconsidering the usefulness of adding naloxone to buprenorphine. Frontiers in Psychiatry, 11, 549272.
5. Bruchas, M. R., Land, B. B., & Chavkin, C. (2010). The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Research, 1314, 44–55.